Mihailo Banjanac

642 total citations
24 papers, 520 citations indexed

About

Mihailo Banjanac is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Mihailo Banjanac has authored 24 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Organic Chemistry, 8 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Mihailo Banjanac's work include Synthesis and biological activity (8 papers), Synthesis and Biological Evaluation (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Mihailo Banjanac is often cited by papers focused on Synthesis and biological activity (8 papers), Synthesis and Biological Evaluation (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). Mihailo Banjanac collaborates with scholars based in Croatia, Belgium and Slovenia. Mihailo Banjanac's co-authors include Vesna Eraković Haber, Vesna Munić Kos, Krunoslav Nujić, Denis Polančec, Martina Bosnar, Mario Hlevnjak, Tihomir Tomašič, Sotirios Katsamakas, Matjaž Brvar and Žiga Hodnik and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Mihailo Banjanac

22 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mihailo Banjanac Croatia 12 150 119 96 96 76 24 520
Joo‐Youn Lee South Korea 15 282 1.9× 102 0.9× 117 1.2× 76 0.8× 38 0.5× 66 638
José Prisco Palma‐Nicolás Mexico 13 211 1.4× 70 0.6× 117 1.2× 89 0.9× 41 0.5× 29 553
Nivedita Bhardwaj India 11 153 1.0× 85 0.7× 64 0.7× 118 1.2× 30 0.4× 37 483
Man Gao China 17 281 1.9× 77 0.6× 118 1.2× 49 0.5× 42 0.6× 43 692
Dengfeng Dou United States 17 248 1.7× 230 1.9× 35 0.4× 44 0.5× 33 0.4× 28 656
Isabel Zeitträger Germany 9 128 0.9× 87 0.7× 146 1.5× 41 0.4× 29 0.4× 9 401
Zhiguang Ren China 16 272 1.8× 83 0.7× 152 1.6× 53 0.6× 25 0.3× 33 604
Riyasat Ali India 13 139 0.9× 40 0.3× 104 1.1× 90 0.9× 17 0.2× 26 500
Yutaka Tatano Japan 14 188 1.3× 73 0.6× 118 1.2× 88 0.9× 20 0.3× 31 482
Noboru Uchide Japan 14 145 1.0× 57 0.5× 267 2.8× 239 2.5× 48 0.6× 29 608

Countries citing papers authored by Mihailo Banjanac

Since Specialization
Citations

This map shows the geographic impact of Mihailo Banjanac's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mihailo Banjanac with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mihailo Banjanac more than expected).

Fields of papers citing papers by Mihailo Banjanac

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mihailo Banjanac. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mihailo Banjanac. The network helps show where Mihailo Banjanac may publish in the future.

Co-authorship network of co-authors of Mihailo Banjanac

This figure shows the co-authorship network connecting the top 25 collaborators of Mihailo Banjanac. A scholar is included among the top collaborators of Mihailo Banjanac based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mihailo Banjanac. Mihailo Banjanac is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Starčević, Kristina, et al.. (2024). Novel iminocoumarin imidazo[4,5-b]pyridine derivatives: design, synthesis, and biological evaluation. Chemistry of Heterocyclic Compounds. 60(1-2). 75–82.
3.
Persoons, Leentje, et al.. (2023). Novel Biologically Active N-Substituted Benzimidazole Derived Schiff Bases: Design, Synthesis, and Biological Evaluation. Molecules. 28(9). 3720–3720. 18 indexed citations
4.
Perin, Nataša, Leentje Persoons, Dirk Daelemans, et al.. (2022). Biological evaluation of novel bicyclic heteroaromatic benzazole derived acrylonitriles: synthesis, antiproliferative and antibacterial activity. Medicinal Chemistry Research. 31(8). 1339–1350. 2 indexed citations
5.
Avbelj, Martina, et al.. (2021). Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63. Molecules. 26(22). 6825–6825. 17 indexed citations
6.
Racanè, Livio, Nataša Perin, Mihailo Banjanac, et al.. (2021). Biological Activity of Newly Synthesized Benzimidazole and Benzothizole 2,5-Disubstituted Furane Derivatives. Molecules. 26(16). 4935–4935. 21 indexed citations
7.
Banjanac, Mihailo, et al.. (2020). Discovery of macrozones, new antimicrobial thiosemicarbazone-based azithromycin conjugates: design, synthesis and in vitro biological evaluation. International Journal of Antimicrobial Agents. 56(5). 106147–106147. 14 indexed citations
8.
Banjanac, Mihailo, et al.. (2020). Precision-cut lung slices as an in vitro model for testing of novel therapeutic agents. 2893–2893. 1 indexed citations
9.
Perić, Mihaela, Sulejman Alihodžić, Esperanza Herreros, et al.. (2020). A novel class of fast‐acting antimalarial agents: Substituted 15‐membered azalides. British Journal of Pharmacology. 178(2). 363–377. 9 indexed citations
10.
Banjanac, Mihailo, et al.. (2019). Precision-cut lung slices from bleomycin treated animals as a model for testing potential therapies for idiopathic pulmonary fibrosis. Pulmonary Pharmacology & Therapeutics. 55. 75–83. 27 indexed citations
11.
12.
Paljetak, Hana Čipčić, Donatella Verbanac, Jasna Padovan, et al.. (2016). Macrolones Are a Novel Class of Macrolide Antibiotics Active against Key Resistant Respiratory Pathogens In Vitro and In Vivo. Antimicrobial Agents and Chemotherapy. 60(9). 5337–5348. 17 indexed citations
13.
Nujić, Krunoslav, Mihailo Banjanac, Vesna Munić Kos, Denis Polančec, & Vesna Eraković Haber. (2012). Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype. Cellular Immunology. 279(1). 78–86. 58 indexed citations
14.
Banjanac, Mihailo, Vesna Munić Kos, Krunoslav Nujić, et al.. (2012). Anti-inflammatory mechanism of action of azithromycin in LPS-stimulated J774A.1 cells. Pharmacological Research. 66(4). 357–362. 51 indexed citations
15.
Kos, Vesna Munić, Jovica Ralić, Barbara Stanić, et al.. (2012). Macrolactonolides: A novel class of anti-inflammatory compounds. Bioorganic & Medicinal Chemistry. 21(1). 321–332. 11 indexed citations
16.
Nujić, Krunoslav, Mihailo Banjanac, Vesna Munić Kos, Denis Polančec, & Vesna Eraković Haber. (2012). Impairment of lysosomal functions by azithromycin and chloroquine contributes to anti-inflammatory phenotype. Cell Immunol. 1 indexed citations
17.
Kos, Vesna Munić, Mihailo Banjanac, Sanja Koštrun, et al.. (2011). Intensity of macrolide anti-inflammatory activity in J774A.1 cells positively correlates with cellular accumulation and phospholipidosis. Pharmacological Research. 64(3). 298–307. 34 indexed citations
18.
Kos, Vesna Munić, Mihailo Banjanac, Snježana Čužić, et al.. (2011). Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. Journal of Leukocyte Biology. 91(2). 229–243. 41 indexed citations
19.
Banjanac, Mihailo, Krunoslav Nujić, Martina Bosnar, et al.. (2011). Azithromycin distinctively modulates classical activation of human monocytes in vitro. British Journal of Pharmacology. 165(5). 1348–1360. 88 indexed citations
20.
Banjanac, Mihailo, et al.. (2009). Pyrimido-Pyrimidines: A Novel Class of Dihydrofolate Reductase Inhibitors. SHILAP Revista de lepidopterología. 47(3). 236–245. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joo‐Youn Lee Breakdown of academic impact, for papers by José Prisco Palma‐Nicolás Breakdown of academic impact, for papers by Nivedita Bhardwaj Breakdown of academic impact, for papers by Man Gao Breakdown of academic impact, for papers by Dengfeng Dou Breakdown of academic impact, for papers by Isabel Zeitträger Breakdown of academic impact, for papers by Zhiguang Ren Breakdown of academic impact, for papers by Riyasat Ali Breakdown of academic impact, for papers by Yutaka Tatano Breakdown of academic impact, for papers by Noboru Uchide
Rankless by CCL
2026